TDOC
Income statement / Annual
Last year (2023), Teladoc Health, Inc.'s total revenue was $2.60 B,
an increase of 8.13% from the previous year.
In 2023, Teladoc Health, Inc.'s net income was -$220.37 M.
See Teladoc Health, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$2.60 B
|
$2.41 B
|
$2.03 B
|
$1.09 B
|
$553.31 M
|
$417.91 M
|
$233.28 M
|
$123.16 M
|
$77.38 M
|
$43.53 M
|
| Cost of Revenue |
$760.03 M |
$743.99 M |
$650.26 M |
$390.83 M |
$184.47 M |
$128.74 M |
$61.62 M |
$31.97 M |
$21.04 M |
$9.93 M |
| Gross Profit |
$1.84 B |
$1.66 B |
$1.38 B |
$703.13 M |
$368.84 M |
$289.17 M |
$171.66 M |
$91.19 M |
$56.34 M |
$33.60 M |
| Gross Profit Ratio |
0.71 |
0.69 |
0.68 |
0.64 |
0.67 |
0.69 |
0.74 |
0.74 |
0.73 |
0.77 |
| Research and Development
Expenses |
$348.52 M
|
$333.63 M
|
$311.88 M
|
$164.94 M
|
$64.64 M
|
$54.37 M
|
$34.46 M
|
$21.82 M
|
$14.21 M
|
$7.57 M
|
| General & Administrative
Expenses |
$464.66 M
|
$449.86 M
|
$438.01 M
|
$506.68 M
|
$164.46 M
|
$118.78 M
|
$81.27 M
|
$52.69 M
|
$54.84 M
|
$19.62 M
|
| Selling & Marketing
Expenses |
$902.63 M
|
$850.71 M
|
$667.31 M
|
$380.20 M
|
$174.61 M
|
$144.26 M
|
$95.65 M
|
$60.96 M
|
$38.21 M
|
$19.23 M
|
| Selling, General &
Administrative Expenses |
$1.37 B
|
$1.30 B
|
$1.11 B
|
$886.88 M
|
$339.07 M
|
$263.05 M
|
$176.91 M
|
$113.65 M
|
$93.06 M
|
$38.86 M
|
| Other Expenses |
$4.45 M |
$256.03 M |
$204.24 M |
$69.50 M |
$38.95 M |
$37.72 M |
$22.48 M |
$11.43 M |
$4.86 M |
$2.32 M |
| Operating Expenses |
$2.05 B |
$1.89 B |
$1.62 B |
$1.12 B |
$442.66 M |
$355.14 M |
$233.85 M |
$146.89 M |
$112.13 M |
$48.75 M |
| Cost And Expenses |
$2.81 B |
$2.63 B |
$2.27 B |
$1.51 B |
$627.13 M |
$483.87 M |
$295.48 M |
$178.86 M |
$133.17 M |
$58.68 M |
| Interest Income |
$46.78 M |
$9.27 M |
$80.37 M |
$59.95 M |
$29.36 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$22.28 M |
$9.27 M |
$80.37 M |
$60.50 M |
$29.01 M |
$26.11 M |
$17.49 M |
$2.59 M |
$2.20 M |
$1.50 M |
| Depreciation &
Amortization |
$351.32 M
|
$270.64 M
|
$219.62 M
|
$78.09 M
|
$38.95 M
|
$35.60 M
|
$19.10 M
|
$8.27 M
|
$4.86 M
|
$2.32 M
|
| EBITDA |
$192.05 M
|
$13.47 B
|
-$14.28 M
|
-$340.10 M
|
-$28.87 M
|
-$30.36 M
|
-$43.10 M
|
-$47.44 M
|
-$50.92 M
|
-$12.83 M
|
| EBITDA Ratio |
0.07 |
5.6 |
-0.01 |
-0.31 |
-0.05 |
-0.07 |
-0.18 |
-0.39 |
-0.66 |
-0.29 |
| Operating Income Ratio
|
-0.1
|
5.48
|
-0.12
|
-0.38
|
-0.13
|
-0.17
|
-0.32
|
-0.51
|
-0.72
|
-0.35
|
| Total Other
Income/Expenses Net |
-$33.61 M
|
-$26.86 B
|
-$145.67 M
|
-$157.81 M
|
-$35.63 M
|
-$4.89 M
|
-$27.32 M
|
-$15.41 M
|
-$2.20 M
|
-$1.50 M
|
| Income Before Tax |
-$219.61 M |
-$13.66 B |
-$384.66 M |
-$575.99 M |
-$109.46 M |
-$96.97 M |
-$107.01 M |
-$73.71 M |
-$57.98 M |
-$16.65 M |
| Income Before Tax Ratio
|
-0.08
|
-5.68
|
-0.19
|
-0.53
|
-0.2
|
-0.23
|
-0.46
|
-0.6
|
-0.75
|
-0.38
|
| Income Tax Expense |
$760,000.00 |
-$3.81 M |
$44.14 M |
-$90.86 M |
-$10.59 M |
$118,000.00 |
-$225,000.00 |
$510,000.00 |
$36,000.00 |
$388,000.00 |
| Net Income |
-$220.37 M |
-$13.66 B |
-$428.79 M |
-$485.14 M |
-$98.86 M |
-$97.08 M |
-$106.78 M |
-$74.22 M |
-$58.02 M |
-$17.04 M |
| Net Income Ratio |
-0.08 |
-5.68 |
-0.21 |
-0.44 |
-0.18 |
-0.23 |
-0.46 |
-0.6 |
-0.75 |
-0.39 |
| EPS |
-1.34 |
-84.6 |
-2.73 |
-5.36 |
-1.38 |
-1.47 |
-1.93 |
-1.75 |
-2.91 |
-0.62 |
| EPS Diluted |
-1.34 |
-84.6 |
-2.73 |
-5.36 |
-1.38 |
-1.47 |
-1.93 |
-1.75 |
-2.91 |
-0.62 |
| Weighted Average Shares
Out |
$164.58 M
|
$161.46 M
|
$156.94 M
|
$90.51 M
|
$71.84 M
|
$65.84 M
|
$55.43 M
|
$42.33 M
|
$19.92 M
|
$27.61 M
|
| Weighted Average Shares
Out Diluted |
$164.58 M
|
$161.46 M
|
$156.94 M
|
$90.51 M
|
$71.84 M
|
$65.84 M
|
$55.43 M
|
$42.33 M
|
$19.92 M
|
$27.61 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
